Navigation Links
Barr in Biological Technology

Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Barr Laboratories, Inc. ("Barr") for infringement of three of ...

Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), announces that it has received Paragraph IV Notice letters from Barr Laboratories, Inc. ("Barr) and Mylan, Inc. ("Mylan) dated 2 and 4 February 2009 respectively, advisi...

Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals

FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: EURX ) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharma...

Teva and Barr Provide Update on Acquisition

- Barr Announces Debt Amendment - Teva Announces Sufficient Funds to Complete Acquisition JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: BRL ) announced today that Barr and ...

Teva to Acquire Barr

Significantly Strengthens Teva's Market Leadership Position in the U.S. and in Key Global Markets Acquisition Expected to Be Accretive in the Fourth Quarter after Closing JERUSALEM and MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd....

Progenitor Cell Therapy Appoints VP of Manufacturing Operations

...ty and enhance operational efficiencies. Prior to joining PCT, Daryl served as Vice President, Operations, Pomona, East Hanover and Northvale for barr Laboratories. Before joining Barr, Daryl served as Vice President of Pharmaceutical Production at Novartis Pharmaceutical Corporation. At Novartis, h...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...pean Markets II-66 Artemis to Introduce IGRT II-66 Immunomedics Introduces Immunotoxin for Treatment of Prostate and Lung Cancer II-66 barr Unveils Generic Version of Proscar(R) Tablets II-67 IRX Therapeutics to Develop Vaccine for Prostate Cancer II-67 Actavis Introduces New Gener...

Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity

...ough our innovative R&D efforts, our ability to successfully identify, consummate and integrate acquisitions, including the pending acquisition of barr Pharmaceuticals Inc., potential exposure to product liability claims to the extent not covered by insurance, dependence on the effectiveness of our pa...

Shire begins the year with a strong performance

...due to price increases. During March and April, 2009 Shire filed lawsuits in the US District Court of the Southern District of New York against barr Laboratories, Inc. ("Barr"), Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories Inc. (collectively "Mylan") and Natco Pharma Limited ("Nat...

Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member

...cus aureus (MRSA), Pseudomonas and others, and patents covering certain proprietary products targeting pandemic viral infections including, Epstein barr Virus (EBV), human and avian influenza, Hepatitis B and C and other clinical indications. The Company anticipates initiating human clinical trials fo...

Sparta Systems Bolsters Executive Leadership Team with Strategic Additions

...dustry, global technology provider Sun Microsystems and advertising agency J. Walter Thompson. Before Sparta Systems, Marina Aslanyan worked at barr Laboratories as a senior IT leader. During her tenure at Barr, Aslanyan was tasked with improving organizational performance and client satisfaction,...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ad received Paragraph IV Notice letters from barr Laboratories, Inc. ("Barr") and Mylan Inc. (...tail of the Paragraph IV Notice letters from barr and Mylan, and under the Hatch Waxman Act has 45 d...rmation to the FTC relating to its settlement with barr and its earlier settlement with Impax Laboratories...

FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive

... MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...) and other sexually transmitted diseases. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards

...pectus supplement and the accompanying prospectus related to the offering can also be obtained from Boenning & Scattergood, Inc. at 4 Tower Bridge 200 barr Harbor Drive, Suite 300 West Conshohocken, PA 19428; Tel: (610) 684-5427; Fax: (610) 832-0520; Attn: Joyce Englehart. About Oncothyreon Oncothyreo...

Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules

...d release capsules), eq. to 8 mg, 16 mg and 24 mg. barr also announced that it is the first company to fil...e Company intends to launch its product shortly. barr filed its ANDA with the FDA containing a Paragraph... capsule strength of Razadyne ER on March 1, 2006. barr amended its ANDA on March 10, 2006 to include the ...

Barr Receives Approval for Generic Version of Razadyne(R) Tablets

... MONTVALE, N.J., Aug. 28 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, Inc., received final approval from t...ts generic Razadyne tablets product immediately. barr filed an Abbreviated New Drug Application (ANDA) w...

Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)

...inged by the introduction of a generic galantamine hydrobromide product." barr Laboratories and AlphaPharm Pty Ltd. filed Abbreviated New Drug Application...d patent owner Synaptech Inc. filed a patent infringement complaint against barr and AlphaPharm in June 2005. Other lawsuits against generic companies seeki...

Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share

... MONTVALE, N.J., Aug. 7 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported...the benefits that make the proposed acquisition of barr by Teva, announced on July 18th, so attractive. Ma... the close of the transaction, the capabilities of barr will significantly complement Teva's existing busi...

Watson Pharmaceuticals Reports Second Quarter 2008 Results

...plant closure costs. The Company also expects to incur $8.5 million of licensing costs. These and other charges are offset by the sales milestone from barr Pharmaceuticals, the divestiture of the Company's interest in Somerset Pharmaceuticals, Inc. and the resolution of an Internal Revenue Service audit, ...

Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg

... MONTVALE, N.J., July 29 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...FDA that Barr's ANDA had been accepted for filing, barr notified the New Drug Application (NDA) and patent...

Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge

... MONTVALE, N.J., June 26 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...for Delaware has ruled in favor of its subsidiary, barr Laboratories, Inc., in the challenge of the patent...od and Drug Administration (FDA) in February 2008. barr believes that it is the first company to file an A...

Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg

... MONTVALE, N.J., June 10 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...tegrating Tablets (lansoprazole), 15mg and 30mg. barr filed its Abbreviated New Drug Application (ANDA) ...

Barr Confirms Patent Challenge of Entocort(R), 3mg Enteric Coated Capsules

... MONTVALE, N.J., May 27 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...ng a paragraph IV certification for Entocort EC. barr filed its ANDA containing a paragraph IV certifica...

Barr Announces Approval of Generic Yasmin(R)

... MONTVALE, N.J., May 9 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, Inc., has received final approval fr...d by Bayer Schering Pharma, AG. On March 3, 2008 barr announced that the U.S. District Court for the Dis...

Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share

... MONTVALE, N.J., May 8 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported.... Under the terms of this agreement, Allergan paid barr $53 million, extinguishing any future payment obligations related to Sanctura(R). barr will record the $53 million in the Company's secon...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...J, excluding UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SEASONIQUE (trademark of barr Laboratories) VYVANSE(TM) (lisdexamfetamine dimesylate) XAGRID(R) (anagrelide hydrochloride) The following are tradem...

Shire plc: IFRS Results for the Year Ending December 31, 2007

...rmation to the FTC relating to its settlement with barr and its earlier settlement with Impax Laboratories...ng rights in the UK and the Republic of Ireland. barr and other companies have filed ANDA with the FDA f...te. Janssen and Synaptech filed lawsuits against barr and Sandoz Inc. ("Sandoz") for infringement of the...

Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL

...ded January 2008, based on IMS sales data. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...ive pharmaceutical ingredients. A holding company, barr operates through its principal subsidiaries: Barr ...

Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement

... MONTVALE, N.J., March 5 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...rceable or not infringed by Watson's ANDA product. barr has filed to enforce the patent and prevent Watson...mpeting product prior to patent expiry in 2024. If barr is unsuccessful in this litigation, the Company ma...

Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge

... MONTVALE, N.J., March 3 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...hs ended December 2007, based on IMS sales data. barr filed its Abbreviated New Drug Application (ANDA) ...005. Following receipt of the notice from the FDA, barr notified Berlex, the New Drug Application (NDA) ho...

Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter

... MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported...quarter. In the fourth quarter of calendar 2006, barr changed its fiscal year end from June 30th to Dece...cember 31, 2006. In addition, on October 24, 2006, barr acquired PLIVA d.d., a Croatian generics pharmaceu...

Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg

... MONTVALE, N.J., Feb. 26 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...aining a paragraph IV certification for Avodart. barr filed its ANDA containing a paragraph IV certifica...

Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA

... MONTVALE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...) and other sexually transmitted diseases. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...rmation to the FTC relating to its settlement with barr and its earlier settlement with Impax Laboratories...ng rights in the UK and the Republic of Ireland. barr and other companies have filed ANDA with the FDA f...te. Janssen and Synaptech filed lawsuits against barr and Sandoz Inc. ("Sandoz") for infringement of the...

Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg

... MONTVALE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, Inc., has received final approval fr...urt in Delaware. Under the terms of a Court Order, barr has agreed not to launch its Pramipexole Dihydroch...

Barr Launches Generic Fosamax(R) Tablets, 70 mg

... MONTVALE, N.J., Feb. 6 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, Inc., has launched a generic version...ts listed with the FDA for Fosamax, 70 mg tablets. barr obtained favorable resolutions with regard to the ...

Barr and Ortho Women's Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation

... MONTVALE, N.J., Jan. 22 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...r party until a definitive agreement is reached. barr Pharmaceuticals, Inc. is a global specialty pharma...ive pharmaceutical ingredients. A holding company, barr operates through its principal subsidiaries: Barr ...

Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28, 2008

... MONTVALE, N.J., Jan. 18 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...d or install any necessary audio software. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg

... MONTVALE, N.J., Jan. 11 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...(memantine hydrochloride) tablets, 5mg and 10mg. barr filed its Abbreviated New Drug Application (ANDA) ...

Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL

... MONTVALE, N.J., Jan. 9 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, has initiated a challenge of the pat...xaliplatin Aqueous Solution), 5mg/mL Injectable. barr filed an Abbreviated New Drug Application (ANDA) c...
Other Tags
(Date:7/14/2014)... the University of East Anglia have shown how the ... in cancer patients. , Research published today reveals ... responsible for the drug,s success in shrinking tumours. ... develop a synthetic equivalent with anti-cancer properties. ... de Madridin, Spain. The team used samples of human ...
(Date:7/13/2014)... study in women suggests that experiencing one or more ... meal can slow the body,s metabolism, potentially contributing to ... previous day,s stressors before giving them a meal consisting ... scientists then measured their metabolic rate how long ... and took measures of blood sugar, triglycerides, insulin ...
(Date:7/11/2014)... report from the Wildlife Conservation Society shows that ... economically valuable species such as lobster, conch, and ... re-colonize nearby reef areas. , The reporttitled "Review ... review of research literature from no-take areas around ... Craig Dahlgren, a recognized expert in marine protected ...
Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4Belize's lobster, conch, and fish populations rebuild in no-take zones 2
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 2014 Midway through summer, throngs of families ... the National Lampoon classic “Vacation.” An estimated four out of ... by Bridgestone Americas , embark on summer road trips. And ... nagging back pain as the result of hours cramped behind ... , “For these patients, riding in a car for an ...
(Date:7/14/2014)... Institutes of Health (NIH) have identified genetic markers associated ... characterized by high levels of immune cells called eosinophils ... are involved in the development of EoE, which can ... allergies. The findings also may help explain why the ... in part by the Consortium of Food Allergy ...
(Date:7/14/2014)... A recent study published in the July 2014 ... of Child and Adolescent Psychiatry confirms the validity ... criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). , In ... at 7 in DSM-IV, has been raised to 12. ... set at 12, rather than an earlier age, to ...
(Date:7/14/2014)... years that have passed since acupuncture was first ... used to treat a number of physical, mental ... rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia ... Now, a meta-analysis of randomized controlled trials which ... , the journal of The North American Menopause ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 2Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2
Other Contents